Cambridge, MA 10/25/10—Helicos BioSciences has amended its patent infringement suit against Pacific Biosciences (see IBO 9/30/10), naming Illumina and Life Technologies as additional defendants. The suit alleges willful infringement of four patents for sequencing-by-synthesis methods using labeled nucleotides. “After a careful examination of the sequencing products and technologies offered by Illumina and Life Technologies, we […]
Washington, DC 9/21/10; Washington, DC 9/29/10—In a filing with the SEC, Sequenom disclosed that former CFO Paul Hawran has amended a lawsuit to add the company as a defendant. The amended suit adds claims of breach of conduct and negligent misrepresentation. In August, Mr. Hawran filed suit in the Superior Court of California for the […]
Los Angeles, CA 9/8/10—Phenomenex, a supplier of LC columns and sample preparation consumables, has filed suit against Waters in US District Court for the Central District of California. In its complaint, Phenomenex alleges false advertising and unfair competition related to Waters’s promotional material that makes statements about the performance of certain Waters’s LC columns in […]
In IBO’s second part of its annual examination of new and existing litigation among analytical instrument and lab product companies (see IBO 4/30/10), we report on new suits involving third-generation sequencing technologies, as well as one case that may be headed for the Supreme Court. Settlements With the trial set to begin in November in […]
Chicago, IL 9/10/10—Celsis In Vitro (Celsis IVT) announced that the US District Court for the Northern District of Illinois has entered a preliminary injunction against CellzDirect, part of Life Technologies’ Invitrogen business, due to their infringement of US Patent No. 7,604,929 (see IBO 6/30/10). The Patent relates to methods for producing multi-cryopreserved hepatocytes and methods […]
Washington, DC 8/16/10—DNA sequencer developer Pacific Biosciences has filed a registration form with the SEC for an IPO to raise $200 million. The company’s SMRT (single-molecule real-time) sequencing technology provides single-molecule resolution. The company plans to introduce its PacBio RS system in early 2011 at a list price of $695,000, with an initial focus on […]
Washington, DC 6/2/10; San Diego, CA 6/2/10—The SEC has charged Elizabeth A. Dragon, former senior vice president of R&D at Sequenom, with making false statements to investors. The statements were in connection with the genetic test that Sequenom was developing for noninvasive prenatal detection of Down’s syndrome (see IBO 9/30/09). The SEC charges that she […]
Hercules, CA 5/4/10—Bio-Rad Laboratories has announced that as a result of an internal review it has identified conduct in certain overseas operations that may have violated the US Foreign Corrupt Practices Act’s (FCPA) antibribery provisions, books records and internal controls of the FCPA, and the company’s internal policies. Bio-Rad voluntarily disclosed these matters to the […]
In the first of IBO’s twice annual look at US intellectual property cases among instrument and laboratory product companies, cases related to life science technologies predominate. Decisions Wyatt Technology has filed an appeal with the Ninth Circuit Court of Appeals after the US District Court for the Central District of California dismissed its case against […]
Washington, DC 3/26/10—The US Court of Appeals for the Federal Circuit has affirmed the US District Court for the Northern District of California’s rulings in Applied Biosystems’ (Applera) (now Life Technologies) patent infringement suit against Illumina, Stephen C. Macevicz and Solexa regarding next-generation sequencing technology (see IBO 1/31/09, 4/30/09). In the first phase of the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
